FEM1A

FEM1A is a substrate-recognition subunit of CUL2-RING E3 ubiquitin ligase complexes (CRL2FEM1A) that selectively recognizes arginine C-terminal degrons (Arg/C-degrons) to target substrate proteins for ubiquitin-proteasome degradation (PMID:33398168). Crystal structures of FEM1 proteins bound to Arg/C-degron-bearing substrates established that FEM1A, FEM1B, and FEM1C target distinct classes of Arg/C-degron, conferring paralog-specific substrate selectivity (PMID:33398168). A defined physiological substrate is Stem-Loop Binding Protein (SLBP): FEM1A, FEM1B, and FEM1C engage distinct degrons in the SLBP N-terminus and, together with cyclin F, drive its cell-cycle-regulated, oscillating degradation, a regulatory interaction conserved across C. elegans and D. melanogaster (PMID:28118078). The substrate-binding activity is mediated by an N-terminal ankyrin (ANK) repeat domain that constitutes the most conserved region of the protein and identifies FEM1A as the mammalian homolog of the C. elegans sex-determination regulator FEM-1 (PMID:9828124, PMID:11733146). FEM1A additionally localizes to mitochondria in muscle cells and associates with the prostaglandin E2 EP4 receptor (PMID:19406122), and its expression is induced during myocyte differentiation while being downregulated in rhabdomyosarcoma (PMID:16254458); the functional significance of these contexts is not mechanistically characterized in the available corpus.

1. 1998 Medium

   Establishing FEM1A's domain architecture and evolutionary identity was the first step toward inferring its molecular role; cloning revealed it as an ankyrin-repeat protein homologous to the C. elegans sex-determination regulator FEM-1.

   Evidence cDNA cloning, sequence analysis, and Northern blot of mouse Fem1a

   PMID:9828124

   Open questions at the time

   • Domain function inferred by homology, not by mutagenesis
   • No biochemical activity assigned
2. 2001 Medium

   Characterization of the human ortholog confirmed conservation of the ANK-repeat protein and its chromosomal locus, extending the FEM-1 family across species.

   Evidence cDNA cloning, genomic structure determination, and RT-PCR of human FEM1A

   PMID:11733146

   Open questions at the time

   • No functional role tested
   • Substrate and complex membership unknown at this stage
3. 2005 Medium

   Expression profiling tied FEM1A to muscle differentiation and tumor biology, raising the question of its tissue role; it is induced in terminally differentiating myocytes and consistently lost in rhabdomyosarcoma.

   Evidence RT-PCR during C2C12 differentiation and in human RMS lines and primary mouse RMS tumors

   PMID:16254458

   Open questions at the time

   • Correlative expression only, no causal manipulation
   • Mechanism linking FEM1A loss to RMS not defined
4. 2009 Medium

   Subcellular and partner mapping in muscle placed FEM1A at mitochondria and linked it to prostaglandin signaling via the EP4 receptor, contexts distinct from its later-defined ligase role.

   Evidence Immunofluorescence, electron microscopy, fractionation, and Co-IP in C2C12 and cardiac muscle cells

   PMID:19406122

   Open questions at the time

   • EP4 interaction rests on a single pulldown
   • Functional consequence of mitochondrial localization untested
5. 2017 High

   The decisive functional advance identified FEM1A as a CUL2 E3 ligase substrate-recognition subunit with a bona fide substrate, answering what process it controls: cell-cycle-regulated proteolysis of SLBP.

   Evidence Reciprocal Co-IP, protein stability and cell cycle assays, SLBP mutant rescue, and conserved ortholog interaction studies in C. elegans and Drosophila

   PMID:28118078

   Open questions at the time

   • Full substrate repertoire beyond SLBP not enumerated
   • Relationship between this role and the muscle/mitochondrial findings unresolved
6. 2021 High

   Structural work defined the recognition principle, showing FEM1A reads arginine C-terminal degrons and that FEM1A/B/C discriminate distinct Arg/C-degron classes, explaining paralog-specific targeting.

   Evidence Crystal structures of FEM1-degron complexes with binding assays, global protein stability analyses, and active-site validation

   PMID:33398168

   Open questions at the time

   • Genome-wide Arg/C-degron substrate set for FEM1A specifically not fully mapped
   • Regulation of CRL2FEM1A assembly and activity not addressed

• How FEM1A's defined role as a CRL2 Arg/C-degron recognition subunit reconciles with its reported mitochondrial localization, EP4 receptor association, and roles in myogenesis and tumor suppression remains unresolved.
• No mechanistic link between ubiquitin-ligase function and mitochondrial/muscle contexts
• No substrate identified in the muscle or tumor settings